Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC)

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-007-0599-0PMID 17901953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.

  2006cited by this paper
• Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01.

  2006cited by this paper
• Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split‐course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies

  2005cited by this paper
• Neoadjuvant and concomitant chemotherapy and radiation therapy in patients with advanced head and neck carcinoma

  2005cited by this paper
• Organ Preservation and Treatment Toxicity With Induction Chemotherapy Followed by Radiation Therapy or Chemoradiation for Advanced Laryngeal Cancer

  2005cited by this paper
• Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

  2005cited by this paper
• Results of an organ preservation protocol with induction chemotherapy and radiotherapy in patients with locally advanced laryngeal carcinoma

  2004cited by this paper
• Is there a new role for induction chemotherapy in the treatment of head and neck cancer?

  2004cited by this paper
• Is there still a role for neoadjuvant chemotherapy in head and neck cancer?

  2004cited by this paper
• Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU).

  2004cited by this paper
• Standard cisplatin/infusional 5-fluorouracil (PF) vs docetaxel (T) plus PF (TPF) as neoadjuvant chemotherapy for nonresectable locally advanced squamous cell carcinoma of the head andneck (LA-SCCHN): a phase III trial of the EORTC Head and Neck Cancer Group (EORTC #24971).

  2004cited by this paper
• Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

  2003cited by this paper
• Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck

  2003cited by this paper
• Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment.

  2003cited by this paper
• Docetaxel, cisplatin, and 5‐fluorouracil‐based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck

  2003cited by this paper
• Head and neck cancer.

  2001cited by this paper
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

  2001influential reference
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

  2000cited by this paper
• Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

  1998cited by this paper
• Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

  1998cited by this paper
• Phase I study of docetaxel with concomitant thoracic radiation therapy.

  1998cited by this paper
• Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer.

  1997cited by this paper
• Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group.

  1996cited by this paper
• Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial.

  1995cited by this paper
• Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group.

  1994cited by this paper
• Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.

  1994cited by this paper
• Head and Neck Cancer

  1993cited by this paper
• A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neck.

  1993cited by this paper
• Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy.

  1992cited by this paper
• Head and neck cancer.

  1991cited by this paper
• Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.

  1991cited by this paper
• [Phase II study of UFT for head and neck cancer].

  1985cited by this paper
• Cisplatin and 5‐fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

  1984cited by this paper

• Anti-Gastric Cancer Activity of Mixed-Region Iranian Propolis Nanoparticles: Potential Therapeutic Applications

  2025cites this paper
• Overexpression of HURP mRNA in head and neck carcinoma and association with in vitro response to vinorelbine.

  2020cites this paper
• Antidepressants Promote and Prevent Cancers

  2020cites this paper
• Profile of Afatinib and its Potential in the Treatment of Head and Neck Cancer:Current Evidence

  2017cites this paper
• Systemic therapy in the curative treatment of head and neck squamous cell cancer: a systematic review

  2017cites this paper
• Pre-Operative Simultaneous Fractionated Cisplatin and Radiation Therapy in the Treatment of Advanced Stage III and IV Squamous Cell Carcinoma of the Base of Tongue and Hypopharynx

  2017cites this paper
• Tumor heparanase expression in predicting response to induction chemotherapy in patients with locally advanced laryngeal cancer.

  2012cites this paper
• Chimiothérapie d’induction des carcinomes épidermoïdes de la tête et du cou

  2011cites this paper
• [Induction chemotherapy for head and neck epidermoid carcinomas].

  2011cites this paper
• Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.

  2010cites this paper
• Current concepts for the management of head and neck cancer: chemotherapy.

  2009cites this paper
• Place de la chimiothérapie d’induction dans les carcinomes épidermoïdes de la tête et du cou localement avancés inopérables (hors préservation laryngée)

  2009cites this paper
• Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study

  2008cites this paper
• A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update

  2008cites this paper